Candriam S.C.A. Grows Position in GE HealthCare Technologies Inc. $GEHC

Candriam S.C.A. raised its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 177.2% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 64,841 shares of the company’s stock after purchasing an additional 41,453 shares during the quarter. Candriam S.C.A.’s holdings in GE HealthCare Technologies were worth $4,615,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Laurel Wealth Advisors LLC acquired a new position in GE HealthCare Technologies in the 4th quarter worth approximately $26,000. Optima Capital LLC acquired a new stake in GE HealthCare Technologies during the 4th quarter valued at approximately $27,000. Godfrey Financial Associates Inc. acquired a new stake in GE HealthCare Technologies during the 4th quarter valued at approximately $27,000. Montag A & Associates Inc. lifted its stake in GE HealthCare Technologies by 105.4% during the 4th quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock valued at $28,000 after acquiring an additional 175 shares during the period. Finally, Transamerica Financial Advisors LLC boosted its holdings in shares of GE HealthCare Technologies by 331.6% in the 4th quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock valued at $28,000 after acquiring an additional 262 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Up 0.9%

GEHC stock opened at $65.31 on Tuesday. GE HealthCare Technologies Inc. has a 12-month low of $58.75 and a 12-month high of $89.77. The business’s 50-day moving average is $63.52 and its 200 day moving average is $72.45. The company has a current ratio of 1.22, a quick ratio of 0.95 and a debt-to-equity ratio of 0.95. The stock has a market cap of $29.71 billion, a price-to-earnings ratio of 15.62, a PEG ratio of 1.76 and a beta of 0.72.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The firm had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.04 billion. During the same period in the previous year, the company earned $1.01 EPS. GE HealthCare Technologies’s revenue was up 7.4% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.89 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Friday, July 24th will be paid a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend is Friday, July 24th. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.35%.

Insider Buying and Selling at GE HealthCare Technologies

In related news, insider Frank R. Jimenez bought 1,750 shares of the stock in a transaction dated Thursday, April 30th. The shares were acquired at an average cost of $60.45 per share, for a total transaction of $105,787.50. Following the acquisition, the insider directly owned 93,932 shares in the company, valued at approximately $5,678,189.40. This trade represents a 1.90% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO James Saccaro purchased 3,310 shares of the company’s stock in a transaction dated Friday, May 1st. The stock was bought at an average price of $60.60 per share, with a total value of $200,586.00. Following the completion of the transaction, the chief financial officer directly owned 87,471 shares of the company’s stock, valued at approximately $5,300,742.60. This represents a 3.93% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last quarter, insiders acquired 21,847 shares of company stock worth $1,361,355. 0.36% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on GEHC shares. Stifel Nicolaus set a $80.00 price objective on shares of GE HealthCare Technologies in a research note on Wednesday, April 29th. Jefferies Financial Group lowered their price target on shares of GE HealthCare Technologies from $105.00 to $90.00 in a report on Thursday, April 30th. HSBC dropped their target price on GE HealthCare Technologies from $100.00 to $90.00 in a report on Thursday, April 30th. Royal Bank Of Canada assumed coverage on shares of GE HealthCare Technologies in a research note on Tuesday, June 23rd. They set an “outperform” rating and a $80.00 price objective on the stock. Finally, Citigroup restated a “neutral” rating on shares of GE HealthCare Technologies in a research report on Wednesday, July 8th. Ten equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $79.48.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.